Both in Pharmaceuticals
Enveric Biosciences vs Aprea Therapeutics
Over the past year ENVB returned −78.8% and APRE returned −63.2%; their daily moves had a correlation of 0.03.
ENVB −78.8% APRE −63.2%Growth of $1, one year, split-adjusted
| Metric | ENVB | APRE |
|---|---|---|
| Price | $1.50 | $0.5150 |
| Market cap | $6.7M | $6.5M |
| Today | +3.45% | +4.89% |
| 1 month | −0.7% | −23.8% |
| 6 months | −56.9% | −38.9% |
| Year to date | −58.7% | −39.6% |
| 1 year | −73.7% | −63.2% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 1,250.6× |
| Net cash | $8.3M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 96.0% |
| Short % of float | 0.9% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).